0001127602-21-027342.txt : 20211019 0001127602-21-027342.hdr.sgml : 20211019 20211019162149 ACCESSION NUMBER: 0001127602-21-027342 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211015 FILED AS OF DATE: 20211019 DATE AS OF CHANGE: 20211019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hutson Nancy J CENTRAL INDEX KEY: 0001379222 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23186 FILM NUMBER: 211331347 MAIL ADDRESS: STREET 1: 64 MONTAUK AVENUE CITY: STONINGTON STATE: CT ZIP: 06378 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-859-1302 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-10-15 0000882796 BIOCRYST PHARMACEUTICALS INC BCRX 0001379222 Hutson Nancy J 64 MONTAUK AVENUE STONINGTON CT 06378 1 Common Stock 2021-10-15 4 M 0 30000 2.91 A 95073 D Common Stock 2021-10-15 4 M 0 30000 5.13 A 125073 D Common Stock 2021-10-15 4 M 0 15000 1.71 A 140073 D Common Stock 2021-10-15 4 M 0 30000 3.22 A 170073 D Common Stock 2021-10-15 4 S 0 105000 15.40 D 65073 D Automatic Stock Option Grant 2.91 2021-10-15 4 M 0 30000 0 D 2020-05-29 2029-05-29 Common Stock 30000 0 D Automatic Stock Option Grant 5.13 2021-10-15 4 M 0 30000 0 D 2017-06-24 2027-05-24 Common Stock 30000 0 D Automatic Stock Option Grant 1.71 2021-10-15 4 M 0 15000 0 D 2013-06-30 2023-05-31 Common Stock 15000 0 D Automatic Stock Option Grant 3.22 2021-10-15 4 M 0 30000 0 D 2016-06-23 2026-05-23 Common Stock 30000 0 D This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021. The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $15.13 to $15.51. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. /s/ Alane P. Barnes, by power of attorney 2021-10-19